TCG Crossover GP II, LLC 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:22 pm Purchase | 2025-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | TCG Crossover GP II, LLC | 6,243,812 5.700% | 1,600,000 (+34.45%) | Filing |
| 2024-08-26 6:49 pm Purchase | 2024-08-14 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | TCG Crossover GP II, LLC | 4,643,812 6.800% | 4,643,812 (New Position) | Filing |